First Trust Advisors LP Reduces Holdings in Globe Life Inc. $GL

First Trust Advisors LP lowered its position in shares of Globe Life Inc. (NYSE:GL) by 13.3% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 170,017 shares of the company’s stock after selling 25,984 shares during the period. First Trust Advisors LP’s holdings in Globe Life were worth $23,661,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Hilton Head Capital Partners LLC acquired a new position in Globe Life in the fourth quarter valued at approximately $30,000. CYBER HORNET ETFs LLC acquired a new stake in Globe Life during the second quarter worth $28,000. MUFG Securities EMEA plc acquired a new stake in Globe Life during the second quarter worth $31,000. Torren Management LLC purchased a new stake in Globe Life in the fourth quarter valued at $37,000. Finally, AdvisorNet Financial Inc raised its position in Globe Life by 41.1% in the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after purchasing an additional 92 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Stock Up 0.3%

Shares of NYSE GL opened at $179.69 on Thursday. The firm has a market cap of $13.95 billion, a price-to-earnings ratio of 11.93 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55. The business’s 50 day moving average is $170.49 and its two-hundred day moving average is $153.78.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the company earned $3.05 earnings per share. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts predict that Globe Life Inc. will post 15.73 EPS for the current year.

Insider Activity at Globe Life

In related news, Director Cheryl Alston sold 8,258 shares of the stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the transaction, the director owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. This represents a 33.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 25,650 shares of the firm’s stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total value of $4,580,577.00. Following the transaction, the chief financial officer owned 50,568 shares of the company’s stock, valued at $9,030,433.44. This trade represents a 33.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 111,174 shares of company stock worth $18,162,909. 2.11% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on GL shares. JPMorgan Chase & Co. upped their price target on Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Keefe, Bruyette & Woods reduced their price objective on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. Jefferies Financial Group boosted their price objective on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday, July 10th. Truist Financial upped their target price on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. Finally, Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $191.67.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.